International Sustainable Forestry Coalition Welcomes New Member, Sumitomo Forestry
In September 2023, an international group of leading sustainable forestry companies launched the International Sustainable Forestry Coalition (ISFC) to support an increased contribution of the forestry sector to the transition to a sustainable society.
Today the ISFC is delighted to announce that Sumitomo Forestry has joined the coalition.
Sumitomo Forestry, headquartered in Tokyo, Japan, is a globally respected forestry sector leader with a long and honourable history. The Company’s history dates back to the seventeenth century when the Sumitomo family opened a copper mine in the Southern part of Japan and sourced timber for fuel and construction as well. Now, the company operates across the forestry value chain from forestry management, to wood processing, trading, wooden construction and biomass power generation. The firm is pursuing a long-term vision for the role of the forestry sector in the decarbonized society.
Sumitomo Forestry manages sustainable working forests in Japan, Indonesia, New Zealand, and Papua New Guinea. It produces sustainable fibre-based building products and operates wooden construction businesses worldwide.
Convening Chair of the ISFC, Dr. David Brand said, “Sumitomo Forestry brings to the group a wealth of experience and is completely aligned around our principles as we all seek to support the transition to a circular bio-economy and sustainable land use systems that contribute to climate change mitigation and adaptation and the conservation of nature.”
President of Sumitomo Forestry Mr. Toshiro Mitsuyoshi said, “accelerating sustainable forestry and promoting wood products and wooden construction play a critical role in the decarbonization transition. By joining the ISFC, we can collectively contribute to seeing the value of sustainable forestry practices and wood products be recognized and this view prevails. We look forward to working with the members of the ISFC towards creating the decarbonized society and beyond.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AWS to Launch an Infrastructure Region in Mexico26.2.2024 17:50:00 EET | Press release
Amazon Web Services (AWS), an Amazon.com, Inc. company (NASDAQ:AMZN), today announced plans to launch an AWS infrastructure Region in Mexico by early 2025. The new AWS Mexico (Central) Region will give developers, startups, entrepreneurs, and enterprises, as well as government, education, and nonprofit organizations, greater choice for running their applications and serving end users from data centers located in Mexico, ensuring that customers who want to store their content in Mexico can do so. As part of its long-term commitment to Latin America, AWS is planning to invest more than $5 billion (approx. MXN $85 billion) in Mexico over 15 years. The upcoming AWS Mexico Region is the latest in AWS’s ongoing investments in Mexico to provide customers with advanced and secure cloud technologies. For more information about AWS Global Infrastructure, visit aws.amazon.com/about-aws/global-infrastructure. “Cloud services are an essential part of everyday life, helping us to digitally and econo
Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair26.2.2024 17:19:00 EET | Press release
Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announced today that preeminent ophthalmologist Eric D. Donnenfeld, MD will Chair its U.S. Medical Advisory Board (MAB) which includes Richard Lindstrom, MD (Minnesota), Vance Thompson, MD (South Dakota), Preeya Gupta, MD (North Carolina), Paul Karpecki, OD (Kentucky), Lisa Nijm, MD, JD (Illinois), and Selina McGee, OD (Oklahoma). Dr. Donnenfeld joins the MAB as Nordic Pharma prepares to launch a novel therapy for Dry Eye Disease, LACRIFILL® canalicular gel. The FDA-cleared hyaluronic acid derivative LACRIFILL is intended to temporarily block tear drainage by the occlusion of the canalicular system. “Nordic Pharma continues to build a world class group of key opinion leaders with Eric agreeing to lead our esteemed MAB in the U.S. as we prepare to bring LACRIFILL to market. With over 30 years of clinical experience as an internationally recognized expert and pioneer in refractive, cornea and catarac
Adtran recognized among STL Partners’ top 100 edge computing companies for 202426.2.2024 16:00:00 EET | Press release
Adtran today announced that it has been recognized as one of STL Partners’ top 100 edge computing companies for 2024, marking its second consecutive year of inclusion on the list. The acknowledgment reaffirms Adtran’s substantial contributions to the sector and highlights its role as a leader, driving innovation amidst the quickly evolving edge computing landscape. This leadership is increasingly vital as more enterprises and service providers seek options beyond centrally deployed, hyperscale clouds to support their business requirements of reducing hosting and backhaul costs, improving service performance and security, and accelerating time to market. This is especially true for the next wave of AI and IoT applications being deployed in various industries, such as manufacturing, transportation, logistics, healthcare, finance, media, retail and the public sector. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226247955/e
Vantage Data Centers Names Two New Regional Presidents to Support Market Growth Amidst Booming Cloud and AI Demand26.2.2024 16:00:00 EET | Press release
Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced the appointments of Dana Adams and David Howson who will serve as regional presidents of North America and EMEA, respectively. The company also announced that Antoine Boniface, who has served as president of EMEA for the past four years, will take on a new role as chief commercial officer for the region. These appointments come as the company enters 2024 positioned for another year of significant growth and expansion across the globe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226667521/en/ Dana Adams has joined Vantage Data Centers as President, North America. (Photo: Business Wire) Adams joins Vantage’s executive leadership team as president of North America, bringing nearly 18 years of experience in the data center sector to the company. Based in Denver, she will oversee the region’s growth, including market developm
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial26.2.2024 16:00:00 EET | Press release
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD), today announced the treatment of the first patient in the CONVERT II Pivotal Trial, a multicenter, international study evaluating the safety and effectiveness of the AeriSeal® System in limiting collateral ventilation in severe COPD/emphysema patients. Collateral ventilation is caused by openings in the lung fissures, or walls between the lung lobes. The AeriSeal System is designed to occlude these naturally occurring openings in a lobe targeted for bronchoscopic lung volume reduction (BLVR) and block collateral ventilation. Successful treatment with the AeriSeal System is followed by treatment with commercially available Zephyr® Valves. Pulmonx received a staged IDE approval by the Food and Drug Administration (FDA) to commence the CONVERT II Pivotal Trial for the AeriSeal System in late 2023. The goal of the CONVERT II Piv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom